Coronary artery calcification in COVID-19 patients : an imaging biomarker for adverse clinical outcomes
Copyright © 2021 Elsevier Inc. All rights reserved..
BACKGROUND: Recent studies have demonstrated a complex interplay between comorbid cardiovascular disease, COVID-19 pathophysiology, and poor clinical outcomes. Coronary artery calcification (CAC) may therefore aid in risk stratification of COVID-19 patients.
METHODS: Non-contrast chest CT studies on 180 COVID-19 patients ≥ age 21 admitted from March 1, 2020 to April 27, 2020 were retrospectively reviewed by two radiologists to determine CAC scores. Following feature selection, multivariable logistic regression was utilized to evaluate the relationship between CAC scores and patient outcomes.
RESULTS: The presence of any identified CAC was associated with intubation (AOR: 3.6, CI: 1.4-9.6) and mortality (AOR: 3.2, CI: 1.4-7.9). Severe CAC was independently associated with intubation (AOR: 4.0, CI: 1.3-13) and mortality (AOR: 5.1, CI: 1.9-15). A greater CAC score (UOR: 1.2, CI: 1.02-1.3) and number of vessels with calcium (UOR: 1.3, CI: 1.02-1.6) was associated with mortality. Visualized coronary stent or coronary artery bypass graft surgery (CABG) had no statistically significant association with intubation (AOR: 1.9, CI: 0.4-7.7) or death (AOR: 3.4, CI: 1.0-12).
CONCLUSION: COVID-19 patients with any CAC were more likely to require intubation and die than those without CAC. Increasing CAC and number of affected arteries was associated with mortality. Severe CAC was associated with higher intubation risk. Prior CABG or stenting had no association with elevated intubation or death.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
Clinical imaging - 77(2021) vom: 15. Sept., Seite 1-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gupta, Yogesh Sean [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers |
|---|
| Anmerkungen: |
Date Completed 21.07.2021 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clinimag.2021.02.016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321599276 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321599276 | ||
| 003 | DE-627 | ||
| 005 | 20231225180155.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinimag.2021.02.016 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1071.xml |
| 035 | |a (DE-627)NLM321599276 | ||
| 035 | |a (NLM)33601125 | ||
| 035 | |a (PII)S0899-7071(21)00071-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gupta, Yogesh Sean |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coronary artery calcification in COVID-19 patients |b an imaging biomarker for adverse clinical outcomes |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.07.2021 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Recent studies have demonstrated a complex interplay between comorbid cardiovascular disease, COVID-19 pathophysiology, and poor clinical outcomes. Coronary artery calcification (CAC) may therefore aid in risk stratification of COVID-19 patients | ||
| 520 | |a METHODS: Non-contrast chest CT studies on 180 COVID-19 patients ≥ age 21 admitted from March 1, 2020 to April 27, 2020 were retrospectively reviewed by two radiologists to determine CAC scores. Following feature selection, multivariable logistic regression was utilized to evaluate the relationship between CAC scores and patient outcomes | ||
| 520 | |a RESULTS: The presence of any identified CAC was associated with intubation (AOR: 3.6, CI: 1.4-9.6) and mortality (AOR: 3.2, CI: 1.4-7.9). Severe CAC was independently associated with intubation (AOR: 4.0, CI: 1.3-13) and mortality (AOR: 5.1, CI: 1.9-15). A greater CAC score (UOR: 1.2, CI: 1.02-1.3) and number of vessels with calcium (UOR: 1.3, CI: 1.02-1.6) was associated with mortality. Visualized coronary stent or coronary artery bypass graft surgery (CABG) had no statistically significant association with intubation (AOR: 1.9, CI: 0.4-7.7) or death (AOR: 3.4, CI: 1.0-12) | ||
| 520 | |a CONCLUSION: COVID-19 patients with any CAC were more likely to require intubation and die than those without CAC. Increasing CAC and number of affected arteries was associated with mortality. Severe CAC was associated with higher intubation risk. Prior CABG or stenting had no association with elevated intubation or death | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Computed tomography (CT) | |
| 650 | 4 | |a Coronary artery calcification (CAC) | |
| 650 | 4 | |a Coronary artery disease (CAD) | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Finkelstein, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Manna, Sayan |e verfasserin |4 aut | |
| 700 | 1 | |a Toussie, Danielle |e verfasserin |4 aut | |
| 700 | 1 | |a Bernheim, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Little, Brent P |e verfasserin |4 aut | |
| 700 | 1 | |a Concepcion, Jose |e verfasserin |4 aut | |
| 700 | 1 | |a Maron, Samuel Z |e verfasserin |4 aut | |
| 700 | 1 | |a Jacobi, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Chung, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Kukar, Nina |e verfasserin |4 aut | |
| 700 | 1 | |a Voutsinas, Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Cedillo, Mario A |e verfasserin |4 aut | |
| 700 | 1 | |a Fernandes, Ajit |e verfasserin |4 aut | |
| 700 | 1 | |a Eber, Corey |e verfasserin |4 aut | |
| 700 | 1 | |a Fayad, Zahi A |e verfasserin |4 aut | |
| 700 | 1 | |a Hota, Partha |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical imaging |d 1996 |g 77(2021) vom: 15. Sept., Seite 1-8 |w (DE-627)NLM012624381 |x 1873-4499 |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2021 |g day:15 |g month:09 |g pages:1-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clinimag.2021.02.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 77 |j 2021 |b 15 |c 09 |h 1-8 | ||